OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(3R,4S,5S,6R)-6-[[(2R,3R,4S,5R,6R)-4-[(2S,3R,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4S,5R,6R)-3,5-dihydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
(5-Thien-2-yl-1H-pyrazol-3-yl)methanol
(R)-3-hydroxyoctanoic acid
(S)-3-hydroxyoctanoic acid
3,4,5-trihydroxy-6-[(3-methoxy-3-oxopropanoyl)oxy]oxane-2-carboxylic acid
3-hydroxyoctanoate
3-hydroxyoctanoic acid
3-Oxo-2,6-dimethyloct-2-enedioic acid CoA
5-Hydroxy-3,7,8,2'-tetramethoxyflavone
afamelanotide
african-1-ene
Benzastatin K
butyrylglutamine
Encelin
Erythrohydrobupropion
GDP-D-glucose(2-)
mollebenzylanol A
mollebenzylanol B
N-(3,5-Dichlorophenyl)succinimide
NADPH
Naphthomycin K
NDP-alpha-D-glucose(2-)
NDP-N-methyl-L-glucosamine
nucleoside 5'-diphosphate
nucleoside 5'-diphosphate(3-)
PI(13:0/14:1(9Z))
poly[(R)-3-hydroxyoctanoate]
Ro 61-8048
taiwankadsurin B
UDP-D-glucose(2-)
EFO: Experimental Factor Ontology
3-hydroxyoctanoate
calcium-binding and coiled-coil domain-containing protein 2
calcium-binding and coiled-coil domain-containing protein 2 (human)
exudative vitreoretinopathy 2, X-linked
family history of prostate cancer
ND00397
NDP (human)
NDP-related vitreoretinopathy
neurodevelopmental disorder with poor language and loss of hand skills
Norrie disease
norrin
norrin (human)
nucleoside diphosphate kinase A
nucleoside diphosphate kinase A measurement
nucleoside diphosphate kinase B
nucleoside diphosphate kinase B (human)
nucleoside diphosphate kinase homolog 7
nucleoside diphosphate kinase homolog 7 (human)
nucleoside diphosphate kinase, mitochondrial
nucleoside diphosphate kinase, mitochondrial (human)
PP interval
PR interval
protein enabled
time spent outdoors measurement
GO: Molecular Function
aldose-1-phosphate nucleotidyltransferase activity
alpha-1,4-glucan glucosyltransferase (NDP-glucose donor) activity
apyrase activity
ATP:ADP adenylyltransferase activity
deoxycytidine kinase activity
deoxynucleotide transmembrane transporter activity
nucleoside diphosphate kinase activity
nucleoside diphosphate phosphatase activity
nucleoside kinase activity
nucleoside monophosphate kinase activity
nucleoside-triphosphate-hexose-1-phosphate nucleotidyltransferase activity
polynucleotide 5'-hydroxyl-kinase activity
sucrose synthase activity
trehalose synthase activity
RDO: RGD Disease Ontology
NEURODEGENERATIVE DISORDER, X-LINKED, FEMALE-RESTRICTED, WITH PARKINSONISM AND
Neurodevelopmental Disorder with Poor Language and Loss of Hand Skills
Norrie disease
X-linked exudative vitreoretinopathy 2
|
|||||||||||||||||||||||||||||||||||||||||||||||||||



















